The tuberous sclerosis 2000 study

presentation initial assessments and implications for diagnosis and management

John R W Yates, Cathy MacLean, J. Nicholas P. Higgins, Ayla Humphrey, Kate le Maréchal, Michelle Clifford, Iris Carcani-Rathwell, Julian R. Sampson, Patrick F. Bolton,

Research output: Contribution to journalArticle

Abstract

Aims: The Tuberous Sclerosis 2000 Study is the first comprehensive longitudinal study of tuberous sclerosis (TS) and aims to identify factors that determine prognosis. Mode of presentation and findings at initial assessments are reported here.

Methods: Children aged 0-16 years newly diagnosed with TS in the UK were evaluated.

Results: 125 children with TS were studied. 114 (91%) met clinical criteria for a definite diagnosis and the remaining 11 (9%) had pathogenic TSC1 or TSC2 mutations. In families with a definite clinical diagnosis, the detection rate for pathogenic mutations was 89%. 21 cases (17%) were identified prenatally, usually with abnormalities found at routine antenatal ultrasound examination. 30 cases (24%) presented before developing seizures and in 10 of these without a definite diagnosis at onset of seizures, genetic testing could have confirmed TS. 77 cases (62%) presented with seizures. Median age at recruitment assessment was 2.7 years (range:4 weeks-18 years). Dermatological features of TS were present in 81%. The detection rate of TS abnormalities was 20/107 (19%) for renal ultrasound including three cases with polycystic kidney disease, 51/88 (58%) for echocardiography, 29/35 (83%) for cranial CT and 95/104 (91%) for cranial MRI. 91% of cases had epilepsy and 65% had intellectual disability (IQ<70).

Conclusions: Genetic testing can be valuable in confirming the diagnosis. Increasing numbers of cases present prenatally or in early infancy, before onset of seizures, raising important questions about whether these children should have EEG monitoring and concerning the criteria for starting anticonvulsant therapy.

Original languageEnglish
Pages (from-to)1020-1025
Number of pages6
JournalArchives of Disease in Childhood
Volume96
Issue number11
Early online date3 Aug 2011
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Tuberous Sclerosis
Seizures
Genetic Testing
Polycystic Kidney Diseases
Mutation Rate
Intellectual Disability
Anticonvulsants
Longitudinal Studies
Echocardiography
Electroencephalography
Epilepsy
Kidney
Mutation

Cite this

Yates, J. R. W., MacLean, C., Higgins, J. N. P., Humphrey, A., le Maréchal, K., Clifford, M. (2011). The tuberous sclerosis 2000 study: presentation initial assessments and implications for diagnosis and management. Archives of Disease in Childhood, 96(11), 1020-1025. https://doi.org/10.1136/adc.2011.211995
Yates, John R W ; MacLean, Cathy ; Higgins, J. Nicholas P. ; Humphrey, Ayla ; le Maréchal, Kate ; Clifford, Michelle ; Carcani-Rathwell, Iris ; Sampson, Julian R. ; Bolton, Patrick F. / The tuberous sclerosis 2000 study : presentation initial assessments and implications for diagnosis and management. In: Archives of Disease in Childhood. 2011 ; Vol. 96, No. 11. pp. 1020-1025.
@article{b8a531205c834775872dfe6add9fe10b,
title = "The tuberous sclerosis 2000 study: presentation initial assessments and implications for diagnosis and management",
abstract = "Aims: The Tuberous Sclerosis 2000 Study is the first comprehensive longitudinal study of tuberous sclerosis (TS) and aims to identify factors that determine prognosis. Mode of presentation and findings at initial assessments are reported here. Methods: Children aged 0-16 years newly diagnosed with TS in the UK were evaluated. Results: 125 children with TS were studied. 114 (91{\%}) met clinical criteria for a definite diagnosis and the remaining 11 (9{\%}) had pathogenic TSC1 or TSC2 mutations. In families with a definite clinical diagnosis, the detection rate for pathogenic mutations was 89{\%}. 21 cases (17{\%}) were identified prenatally, usually with abnormalities found at routine antenatal ultrasound examination. 30 cases (24{\%}) presented before developing seizures and in 10 of these without a definite diagnosis at onset of seizures, genetic testing could have confirmed TS. 77 cases (62{\%}) presented with seizures. Median age at recruitment assessment was 2.7 years (range:4 weeks-18 years). Dermatological features of TS were present in 81{\%}. The detection rate of TS abnormalities was 20/107 (19{\%}) for renal ultrasound including three cases with polycystic kidney disease, 51/88 (58{\%}) for echocardiography, 29/35 (83{\%}) for cranial CT and 95/104 (91{\%}) for cranial MRI. 91{\%} of cases had epilepsy and 65{\%} had intellectual disability (IQ<70). Conclusions: Genetic testing can be valuable in confirming the diagnosis. Increasing numbers of cases present prenatally or in early infancy, before onset of seizures, raising important questions about whether these children should have EEG monitoring and concerning the criteria for starting anticonvulsant therapy.",
author = "Yates, {John R W} and Cathy MacLean and Higgins, {J. Nicholas P.} and Ayla Humphrey and {le Mar{\'e}chal}, Kate and Michelle Clifford and Iris Carcani-Rathwell and Sampson, {Julian R.} and Bolton, {Patrick F.} and Stefano Seri",
year = "2011",
month = "11",
doi = "10.1136/adc.2011.211995",
language = "English",
volume = "96",
pages = "1020--1025",
journal = "Archives of Disease in Childhood",
issn = "0003-9888",
publisher = "BMJ Publishing Group",
number = "11",

}

Yates, JRW, MacLean, C, Higgins, JNP, Humphrey, A, le Maréchal, K, Clifford, M, Carcani-Rathwell, I, Sampson, JR, Bolton, PF 2011, 'The tuberous sclerosis 2000 study: presentation initial assessments and implications for diagnosis and management', Archives of Disease in Childhood, vol. 96, no. 11, pp. 1020-1025. https://doi.org/10.1136/adc.2011.211995

The tuberous sclerosis 2000 study : presentation initial assessments and implications for diagnosis and management. / Yates, John R W; MacLean, Cathy; Higgins, J. Nicholas P.; Humphrey, Ayla; le Maréchal, Kate; Clifford, Michelle; Carcani-Rathwell, Iris; Sampson, Julian R.; Bolton, Patrick F.

In: Archives of Disease in Childhood, Vol. 96, No. 11, 11.2011, p. 1020-1025.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The tuberous sclerosis 2000 study

T2 - presentation initial assessments and implications for diagnosis and management

AU - Yates, John R W

AU - MacLean, Cathy

AU - Higgins, J. Nicholas P.

AU - Humphrey, Ayla

AU - le Maréchal, Kate

AU - Clifford, Michelle

AU - Carcani-Rathwell, Iris

AU - Sampson, Julian R.

AU - Bolton, Patrick F.

AU - Seri, Stefano

PY - 2011/11

Y1 - 2011/11

N2 - Aims: The Tuberous Sclerosis 2000 Study is the first comprehensive longitudinal study of tuberous sclerosis (TS) and aims to identify factors that determine prognosis. Mode of presentation and findings at initial assessments are reported here. Methods: Children aged 0-16 years newly diagnosed with TS in the UK were evaluated. Results: 125 children with TS were studied. 114 (91%) met clinical criteria for a definite diagnosis and the remaining 11 (9%) had pathogenic TSC1 or TSC2 mutations. In families with a definite clinical diagnosis, the detection rate for pathogenic mutations was 89%. 21 cases (17%) were identified prenatally, usually with abnormalities found at routine antenatal ultrasound examination. 30 cases (24%) presented before developing seizures and in 10 of these without a definite diagnosis at onset of seizures, genetic testing could have confirmed TS. 77 cases (62%) presented with seizures. Median age at recruitment assessment was 2.7 years (range:4 weeks-18 years). Dermatological features of TS were present in 81%. The detection rate of TS abnormalities was 20/107 (19%) for renal ultrasound including three cases with polycystic kidney disease, 51/88 (58%) for echocardiography, 29/35 (83%) for cranial CT and 95/104 (91%) for cranial MRI. 91% of cases had epilepsy and 65% had intellectual disability (IQ<70). Conclusions: Genetic testing can be valuable in confirming the diagnosis. Increasing numbers of cases present prenatally or in early infancy, before onset of seizures, raising important questions about whether these children should have EEG monitoring and concerning the criteria for starting anticonvulsant therapy.

AB - Aims: The Tuberous Sclerosis 2000 Study is the first comprehensive longitudinal study of tuberous sclerosis (TS) and aims to identify factors that determine prognosis. Mode of presentation and findings at initial assessments are reported here. Methods: Children aged 0-16 years newly diagnosed with TS in the UK were evaluated. Results: 125 children with TS were studied. 114 (91%) met clinical criteria for a definite diagnosis and the remaining 11 (9%) had pathogenic TSC1 or TSC2 mutations. In families with a definite clinical diagnosis, the detection rate for pathogenic mutations was 89%. 21 cases (17%) were identified prenatally, usually with abnormalities found at routine antenatal ultrasound examination. 30 cases (24%) presented before developing seizures and in 10 of these without a definite diagnosis at onset of seizures, genetic testing could have confirmed TS. 77 cases (62%) presented with seizures. Median age at recruitment assessment was 2.7 years (range:4 weeks-18 years). Dermatological features of TS were present in 81%. The detection rate of TS abnormalities was 20/107 (19%) for renal ultrasound including three cases with polycystic kidney disease, 51/88 (58%) for echocardiography, 29/35 (83%) for cranial CT and 95/104 (91%) for cranial MRI. 91% of cases had epilepsy and 65% had intellectual disability (IQ<70). Conclusions: Genetic testing can be valuable in confirming the diagnosis. Increasing numbers of cases present prenatally or in early infancy, before onset of seizures, raising important questions about whether these children should have EEG monitoring and concerning the criteria for starting anticonvulsant therapy.

UR - http://www.scopus.com/inward/record.url?scp=80054773182&partnerID=8YFLogxK

UR - http://adc.bmj.com/content/96/11/1020

U2 - 10.1136/adc.2011.211995

DO - 10.1136/adc.2011.211995

M3 - Article

VL - 96

SP - 1020

EP - 1025

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 0003-9888

IS - 11

ER -